Delivery Order SPE2DB24D3013-SPE2DB25FFLSR

Award Date 5/14/25
Potential Completion Date 5/15/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,611.33 fixed-price delivery order is for 4566117918 WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,970.24 firm fixed price delivery order is for WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract has an ultimate completion date of December 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,172.14 firm fixed-price delivery order is for WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,798.53 fixed-price delivery order contract is for WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of July 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This federal contract award, valued at $2,425.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567925977 - WEGOVY 1 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,278.78 firm-fixed-price delivery order is for WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of June 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,988.70, is a delivery order for WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of May 14, 2025. This contract award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,457.00, is a Firm Fixed Price Delivery Order to provide WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medical product, to support military healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $3,710.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA). The $3,662.22 firm fixed-price delivery order is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a period of performance through May 15, 2025. The award is not designated as a set-aside and represents an open competition contract. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFLSR
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,612.40 firm fixed price delivery order is for 4568249570 WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, with a period of performance through May 15, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract award was not set aside for any specific business category.

Generated 8/13/25, 11:08 AM